Advisory Board June 13, 2024

According to a new report from U.S. Pharmacopeia (USP), the number of drug shortages in the United States has increased over the last decade — and many of them are lasting much longer than before.

Toolkit: Resources to build a modern and resilient supply chain

Drug shortages continue to increase

For the report, USP analyzed data from FDA and the Center for Drug Evaluation and Research to identify drug shortages in the United States.

Overall, USP found that the number of drug shortages in the United States has increased over the last decade. In December 2023, there were 125 FDA-monitored drug shortages, compared to 82 shortages in December 2014.

Among the 125 shortages at the end of 2023,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech, Survey / Study, Trends
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article